DK3331505T3 - Farmaceutisk sammensætning, som omfatter et atypisk antipsykotisk middel og en fremgangsmåde til fremstilling deraf - Google Patents
Farmaceutisk sammensætning, som omfatter et atypisk antipsykotisk middel og en fremgangsmåde til fremstilling deraf Download PDFInfo
- Publication number
- DK3331505T3 DK3331505T3 DK16742161.9T DK16742161T DK3331505T3 DK 3331505 T3 DK3331505 T3 DK 3331505T3 DK 16742161 T DK16742161 T DK 16742161T DK 3331505 T3 DK3331505 T3 DK 3331505T3
- Authority
- DK
- Denmark
- Prior art keywords
- antipsycotic
- atypical
- procedure
- agent
- manufacturing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20150100356A GR1008842B (el) | 2015-08-06 | 2015-08-06 | Φαρμακευτικο σκευασμα περιεχον εναν ατυπο αντιψυχωσιμο παραγοντα και μεθοδος για την παρασκευη αυτου |
| PCT/EP2016/001164 WO2017020984A1 (en) | 2015-08-06 | 2016-07-07 | Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3331505T3 true DK3331505T3 (da) | 2020-09-14 |
Family
ID=56550161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16742161.9T DK3331505T3 (da) | 2015-08-06 | 2016-07-07 | Farmaceutisk sammensætning, som omfatter et atypisk antipsykotisk middel og en fremgangsmåde til fremstilling deraf |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20180214381A1 (da) |
| EP (1) | EP3331505B1 (da) |
| DK (1) | DK3331505T3 (da) |
| ES (1) | ES2818249T3 (da) |
| GR (1) | GR1008842B (da) |
| HU (1) | HUE051301T2 (da) |
| PL (1) | PL3331505T3 (da) |
| PT (1) | PT3331505T (da) |
| WO (1) | WO2017020984A1 (da) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2321391C2 (ru) | 2002-07-29 | 2008-04-10 | Алза Корпорейшн | Способы и лекарственные формы для контролируемой доставки палиперидона |
| US20070190137A1 (en) | 2005-10-07 | 2007-08-16 | Reyes Iran | Osmotic dosage form with controlled release and fast release aspects |
| ATE530170T1 (de) | 2007-08-21 | 2011-11-15 | Teva Pharma | Paliperidonformulierung mit verzögerter freisetzung |
| WO2009109993A1 (en) * | 2008-02-04 | 2009-09-11 | Torrent Pharmaceuticals Ltd. | Extended release dosage form of paliperidone |
| CA2724533C (en) * | 2008-07-24 | 2014-07-29 | Handa Pharmaceuticals, Llc | Stabilized atypical antipsychotic formulation |
| WO2010089775A2 (en) * | 2009-02-05 | 2010-08-12 | Getz Pharma Research | Improved drug dosage form for controlled delivery of one or more pharmaceutically active agent |
| EP2488162A2 (en) * | 2009-10-16 | 2012-08-22 | Ranbaxy Laboratories Limited | Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof |
| US20130034605A1 (en) * | 2011-08-01 | 2013-02-07 | Micro Labs Limited | Extended release pharmaceutical compositions containing paliperidone |
| US20130064889A1 (en) * | 2011-09-13 | 2013-03-14 | Aptapharma, Inc. | Tablet-in-tablet Palperidone Formulations and Methods for Production and Use Thereof |
-
2015
- 2015-08-06 GR GR20150100356A patent/GR1008842B/el active IP Right Grant
-
2016
- 2016-07-07 DK DK16742161.9T patent/DK3331505T3/da active
- 2016-07-07 ES ES16742161T patent/ES2818249T3/es active Active
- 2016-07-07 HU HUE16742161A patent/HUE051301T2/hu unknown
- 2016-07-07 WO PCT/EP2016/001164 patent/WO2017020984A1/en active Application Filing
- 2016-07-07 EP EP16742161.9A patent/EP3331505B1/en active Active
- 2016-07-07 PT PT167421619T patent/PT3331505T/pt unknown
- 2016-07-07 US US15/749,469 patent/US20180214381A1/en not_active Abandoned
- 2016-07-07 PL PL16742161T patent/PL3331505T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3331505A1 (en) | 2018-06-13 |
| ES2818249T3 (es) | 2021-04-09 |
| GR1008842B (el) | 2016-09-05 |
| US20180214381A1 (en) | 2018-08-02 |
| PL3331505T3 (pl) | 2021-01-25 |
| PT3331505T (pt) | 2020-09-18 |
| HUE051301T2 (hu) | 2021-03-01 |
| WO2017020984A1 (en) | 2017-02-09 |
| EP3331505B1 (en) | 2020-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3347472T3 (da) | Sammensætninger som indeholder cyp76ad1- clade polypeptider og anvendelse heraf. | |
| DK3524603T3 (da) | Fgfr4-hæmmer, fremgangsmåde til fremstilling deraf og farmaceutisk anvendelse deraf | |
| DK3600456T3 (da) | Fremgangsmåde til sterilisering | |
| DK3234093T3 (da) | Proteasevarianter og polynukleotider, som koder for dem | |
| DK3234123T3 (da) | Proteasevarianter og polynukleotider, som koder for dem | |
| DK3313817T3 (da) | Bicycliske derivater, fremgansmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende disse | |
| DK3200615T3 (da) | Kaloriefrie sødestoffer og fremgangsmåder til syntetisering | |
| DK3722274T3 (da) | 2-perfluorbutylpentan til oftalmisk indgivelse | |
| DK3168283T3 (da) | Hydrokrakning-katalysator, fremstillingsfremgangsmåde og anvendelse deraf | |
| DK3313851T3 (da) | Nye hydroxyesterderivativer, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende disse | |
| DK3072835T3 (da) | Fremgangsmåde til fremføring | |
| BR112016030697A2 (pt) | inibidores da desmetilase-1 específica da lisina | |
| DK2986304T3 (da) | Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf. | |
| DK3513809T3 (da) | Medicinsk sammensætning, som omfatter tivozanib | |
| DK3230795T3 (da) | Prægelak og fremgangsmåde til prægning | |
| DK3263110T3 (da) | Tablet, som omfatter et methoxyurinstofderivat og mannitolpartikler | |
| DK3287443T3 (da) | 6-leddet heterocyklisk derivat og farmaceutisk sammensætning, som omfatter dette | |
| DK3094640T3 (da) | Fremgangsmåder til steril kromatografi og fremstilling | |
| DK3227483T3 (da) | Elastisk stof og fremgangsmåde til fremstilling | |
| DK3223796T3 (da) | Farmaceutiske sammensætninger, fremstilling og anvendelser deraf | |
| DK3218351T3 (da) | Fremgangsmåde til fremstilling, isolering og oprensning af farmaceutisk anvendelige former af ahu-377 | |
| DK3071264T3 (da) | Indretning til lægemiddeladministrationsanordning og lægemiddeladministrationsanordning, som omfatter en sådan indretning | |
| DK3348260T3 (da) | Farmaceutisk tramadol-sammensætning til oftalmisk anvendelse | |
| DK3248597T3 (da) | Terapeutisk middel til sensorineuralt høretab | |
| DK3373937T3 (da) | Anti-cd22-antistof-maytansin-konjugater og fremgangsmåder til anvendelse deraf |